Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers
Silvia A. Purro, Andrew J. Nicoll, John Collinge
Biological Psychiatry (2017) Vol. 83, Iss. 4, pp. 358-368
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
Simon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 4, pp. 342-354
Open Access | Times Cited: 76
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease
Christopher H. van Dyck, Haakon B. Nygaard, Kewei Chen, et al.
JAMA Neurology (2019) Vol. 76, Iss. 10, pp. 1219-1219
Open Access | Times Cited: 125
Retinal Degeneration and Alzheimer’s Disease: An Evolving Link
Ajay Ashok, Neena Singh, Suman Chaudhary, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7290-7290
Open Access | Times Cited: 116
Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer’s Amyloid-β Oligomers
Mikhail A. Kostylev, Marcus D. Tuttle, Suho Lee, et al.
Molecular Cell (2018) Vol. 72, Iss. 3, pp. 426-443.e12
Open Access | Times Cited: 106
Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble TauIn Vivo
Tomáš Ondrejčák, Igor Klyubin, Grant T. Corbett, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 50, pp. 10595-10606
Open Access | Times Cited: 86
Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q
Joshua Spurrier, LaShae Nicholson, Xiaotian T. Fang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 647
Open Access | Times Cited: 69
Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease
John H. Viles
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 25
Open Access | Times Cited: 40
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss
Santiago V. Salazar, Timothy Cox, Suho Lee, et al.
Journal of Neuroscience (2018) Vol. 39, Iss. 4, pp. 758-772
Open Access | Times Cited: 70
Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance
Levi M. Smith, Mikhail A. Kostylev, Suho Lee, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 15, pp. 6042-6053
Open Access | Times Cited: 63
Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
Yuan Zhang, Yanfang Zhao, Lei Zhang, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 56
Membrane Interactions and Toxicity by Misfolded Protein Oligomers
Mario Gonzalez-Garcia, Giuliana Fusco, Alfonso De Simone
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Dietary Trace Elements and the Pathogenesis of Neurodegenerative Diseases
Masahiro Kawahara, Midori Kato‐Negishi, Ken‐ichiro Tanaka
Nutrients (2023) Vol. 15, Iss. 9, pp. 2067-2067
Open Access | Times Cited: 17
Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects
Pietro La Vitola, Marten Beeg, Claudia Balducci, et al.
Brain (2018) Vol. 142, Iss. 2, pp. 249-254
Open Access | Times Cited: 52
Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss
Suho Lee, Santiago V. Salazar, Timothy Cox, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 10, pp. 1910-1929
Open Access | Times Cited: 43
Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
Weimin Qiu, Hui Liu, Yijun Liu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1091-1140
Open Access | Times Cited: 13
9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH-SY5Y Cells
Qingmei Sun, Fufeng Liu, Jingcheng Sang, et al.
Marine Drugs (2019) Vol. 17, Iss. 2, pp. 121-121
Open Access | Times Cited: 42
Proteasome Activation to Combat Proteotoxicity
Corey L. Jones, Jetze J. Tepe
Molecules (2019) Vol. 24, Iss. 15, pp. 2841-2841
Open Access | Times Cited: 40
Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists
Erik C. Gunther, Levi M. Smith, Mikhail A. Kostylev, et al.
Cell Reports (2019) Vol. 26, Iss. 1, pp. 145-158.e8
Open Access | Times Cited: 36
The N-terminal domain of the prion protein is required and sufficient for liquid–liquid phase separation: A crucial role of the Aβ-binding domain
Janine Kamps, Yu-Hsuan Lin, Rosario Oliva, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100860-100860
Open Access | Times Cited: 30
Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients
Ujjayini Ghosh, Wai‐Ming Yau, John Collinge, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 30
Aptamer-Induced-Dimerization Strategy Attenuates AβO Toxicity through Modulating the Trophic Activity of PrPC Signaling
Shuya Liu, Shiwei Li, Jirong Lin, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 21, pp. 9264-9270
Closed Access | Times Cited: 21
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Alena Salašová, Giulia Monti, Olav M. Andersen, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein
Austin Stoner, Li Fu, LaShae Nicholson, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice
Anna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0296959-e0296959
Open Access | Times Cited: 4
Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer’s Disease—Are There Connections?
Michał Fułek, Naomi Hachiya, Martyna Gachowska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2097-2097
Open Access
Page 1 - Next Page

Scroll to top